Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
17 [beta]-estradiol and tamoxifen upregulate estrogen receptor [beta] expression and control podocyte signaling pathways in a model of type 2 diabetes
Kidney International, 03/12/09
Catanuto P et al. - The data, combined with improved albumin excretion, reduced glomerular size, and decreased matrix accumulation, suggest that both 17 [beta]-estradiol and tamoxifen may protect podocytes against injury and therefore ameliorate diabetic nephropathy.
Related Articles
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetes
Diabetes Care, 10/28/09
Relevance Score: 69%
The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/06/09
Relevance Score: 68%
Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity
Platelets, 10/30/09
Relevance Score: 68%
Which components of malnutrition–inflammation–atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy
Nephrology, 10/06/09
Relevance Score: 68%
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
Hypertension Research, 11/09/09
Relevance Score: 67%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Response of Secondary Hyperparathyroidism to Cinacalcet Depends on Parathyroid Size
Nephron: Clinical Practice, 12/01/09
Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary IgA nephropathy is more severe in TGF-[beta]1 high secretor patients
Journal of Nephrology, 12/04/09
Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy
Clinical and Experimental Immunology, 12/04/09
Contrast induced nephropathy in urology
Indian Journal of Urology, 12/03/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09
Sirolimus and Cyclosporine A Alter Barrier Function In Renal Proximal Tubular Cells through Stimulation of ERK 1/2 Signaling and Claudin-1 Expression
American Journal of Physiology: Renal Physiology, 12/04/09
Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Article Search
Sponsor


See Latest Articles


